A carregar...
Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies
Chimeric antigen receptor (CAR) T cells are patient T cells that are transduced with genetically engineered synthetic receptors to target a cancer cell surface antigen. The remarkable clinical response rates achieved by adoptive transfer of T cells that target CD19 in patients with leukemia and lymp...
Na minha lista:
Publicado no: | J Thorac Oncol |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738277/ https://ncbi.nlm.nih.gov/pubmed/29107016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.10.001 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|